HIF1A and cervical cancer: Especially, increased expression of HIF-1α and its targets (e. g., vascular endothelial growth factor, hexokinases 2, and GLUT-1) have been reported to correlate with a worse prognosis in cervical cancer patients who received radiotherapy or chemoradiotherapy34–37.